Eterna Therapeutics
ERNA
ERNA
31 hedge funds and large institutions have $2.44M invested in Eterna Therapeutics in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
57% less capital invested
Capital invested by funds: $5.66M → $2.44M (-$3.21M)
60% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 10
Holders
31
Holding in Top 10
–
Calls
$42K
Puts
$11K
Top Buyers
| 1 | +$1.12M | |
| 2 | +$234K | |
| 3 | +$114K | |
| 4 |
VF
Virtu Financial
New York
|
+$27.6K |
| 5 |
Man Group
London,
United Kingdom
|
+$20.7K |
Top Sellers
| 1 | -$1.49M | |
| 2 | -$977K | |
| 3 | -$814K | |
| 4 |
JP Morgan Chase
New York
|
-$331K |
| 5 |
BlackRock
New York
|
-$252K |